14 mar: Årsrapport for SKAKO A/S for 2018
14 mar: TryghedsGruppens kandidater til Tryg A/S bestyrelse
14-03-2019 17:09:23

Final transactions in relation to share buyback program

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on market abuse and the delegated regulation (EU) no. 2016/1052 of 8 March 2016, also referred to as the Safe Harbor rules (company announcement no. 15 of May 2, 2018).

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program. Under the share buyback program, initiated on May 2, 2018 and concluded on March 13, 2019, GN has bought back shares for an amount of DKK 1,000 million.

The following transactions have been made under the program in the period March 12, 2019 – March 13, 2019

 

No. of shares

Average purchase price, DKK

Transaction Value, DKK

  March 12, 201925,247312.017,877,372
  March 13, 201921,063308.286,493,377

Accumulated under the program

3,576,464

279.61

999,999,746

Following the above transactions GN holds a total of 14,313,505 own shares corresponding to a nominal value of DKK 57,254,020 and 9.8% of the total share capital and the total voting rights in the company. During the program, GN has repurchased a total of 3,576,464 shares, which equals a total transaction value of DKK 1,000 million.

As communicated in the Annual Report 2018, as part of the 2017 - 2019 strategy, the board of directors intends to initiate a new DKK 1 billion share buyback program shortly after the annual general meeting following relevant authorizations.

For further information, please contact:

Investors and analysts

Peter Justesen

VP – Investor Relations & Treasury

Tel: +45 45 75 87 16

Or

Rune Sandager

Senior Manager Investor Relations 

Tel: +45 45 75 92 57

Press and the media

Lars Otto Andersen-Lange

Head of Media Relations & Corporate Public Affairs

Tel: +45 45 75 02 55

About GN Group

The GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Our ambitious 150-year journey has taken us from telegraph cables to radio waves and intelligent audio engineering. To celebrate our anniversary, we look to our unique competences within medical, professional and consumer audio solutions to help us continue to transform lives through the power of sound. 

GN was founded with a truly innovative and global mindset. Today, we honor that legacy with world-leading expertise in the human ear, sound, wireless technology, miniaturization and collaborations with leading technology partners. GN's solutions are marketed by the brands ReSound, Beltone, Interton, Jabra and BlueParrott in 100 countries. Founded in 1869, the GN Group employs 6,000 people and is listed on Nasdaq Copenhagen (GN.CO).

Visit our homepage GN.com - and connect with us on LinkedIn, Facebook and Twitter.

Attachments

logo.png

Relateret indhold
11:22 - 
GN: Amerikansk Audio-rival skifter navn efter milliardo..
13 mar - 
GN Hearing/CEO: Vi skal kunne træffe gode beslutninger ..
11 mar - 
GN har landet opkøb
Relateret debat
27 feb - 
Ja, det er korrekt. Her er data jeg har brugt - bemærk ..
27 feb - 
Er det Pe tal på tidspunkt for aflæggelse af årsrapport..
27 feb - 
Ja, det må man sige, der er store forventninger til fre..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Novo og Teva indgår milliardforlig i patentstrid

18-03-2019 12:42:38
Novo Nordisk har indgået forlig med Teva Pharmaceuticals i en patentsag om den storsælgende GLP-1-analog Victoza, som Teva har udfordret patentet på.Aftalen betyder, at Teva kan lancere en generisk version (kopiversion) af Victoza tidligst den 22. december 2023.Det fremgår af en meddelelse fra Novo Nordisk mandag middag.Under visse særlige omstændigheder er der dog også mulighed for, at Tevas vers..

Ambu-produkt sparer omkostninger på amerikanske hospitaler

18-03-2019 11:42:11
Et nyt amerikansk studie viser, at engangsbronkoskoper til kikkertundersøgelser af luftvejene er billigere i brug end genanvendelige skoper.Det skriver Ambu, der selv sælger engangsløsninger til amerikanske hospitaler, i en pressemeddelelse.Ifølge Ambu viser studiet, at ekstraomkostningerne ved brug af et genanvendeligt bronkoskop er på 150 dollar i gennemsnit på de hospitaler, der indgik i studie..

Ugens regnskaber og nøgletal – Rentemøde, Porsche og olie-lagre

Relaterede nyheder
18-03-2019 09:15:22
Mandag, den 18. marts Danske Bank holder generalforsamlingTirsdag, den 19. martsMakrotalTysklandKl. 11:00 ZEW-tal (Marts) Tidligere: 13,4 Forventet: 11,0RegnskaberPorscheFedExWilliam Demant Holding Onsdag, den 20. martsMakrotalStorbritannien:Kl. 10:30 Forbrugerprisindeks (år/år, februar) Tidligere: 1,8% Forventet: 1,8%Kl. (tidspunkt ikke fastlagt) Brexit-afstemning i det britiske parlament USAKl. ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Danske Bank i fokus i ventet grøn start
2
Novo og Teva indgår milliardforlig i patentstrid
3
Ugens regnskaber og nøgletal – Rentemøde, Porsche og olie-lagre
4
Middag: Jyske, Sydbank og Danske får rygstød af bryllupsklokker
5
Amerikansk rentemøde kan give markedet et skub op

Relaterede aktiekurser

GN Store Nord A/S 313,40 0,3% Stigning i aktiekurs
GN Store Nord Ord Shs 313,40 0,3% Stigning i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. marts 2019 14:47:21
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20190215.1 - EUROWEB5 - 2019-03-18 14:47:21 - 2019-03-18 14:47:21 - 1 - Website: OKAY